NPSP558
PAR-C10-008
Phase 3 small_molecule completed
Quick answer
NPSP558 for Hypoparathyroidism is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 3 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Hypoparathyroidism
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed